Kamada Ltd. (TLV:KMDA)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
2,672.00
+15.00 (0.56%)
Jun 26, 2025, 5:24 PM IDT
43.50%
Market Cap 1.54B
Revenue (ttm) 622.70M
Net Income (ttm) 59.80M
Shares Out 57.51M
EPS (ttm) 1.05
PE Ratio 25.56
Forward PE 22.66
Dividend 0.73 (0.03%)
Ex-Dividend Date Mar 17, 2025
Volume 22,745
Average Volume 41,098
Open 2,689.00
Previous Close 2,657.00
Day's Range 2,643.00 - 2,689.00
52-Week Range 1,822.00 - 3,045.00
Beta 0.13
RSI 69.48
Earnings Date Aug 13, 2025

About Kamada

Kamada Ltd. manufactures and sells plasma-derived protein therapeutics. Its products include KAMRAB/KEDRAB indicated as prophylaxis of rabies; CYTOGAM for prophylaxis of Cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplants; VARIZIG for post exposure prophylaxis of varicella; WINRHO SDF for immune thrombocytopenic purpura and suppression of rhesus isoimmunization; HEPAGAM B for prevention of hepatitis B recurrence liver transplants and post-exposure prophylaxis; GLASSIA for intravenous AATD; KAMRHO (D) IM f... [Read more]

Sector Healthcare
Founded 1990
Employees 420
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol KMDA
Full Company Profile

Financial Performance

In 2024, Kamada's revenue was $160.95 million, an increase of 12.93% compared to the previous year's $142.52 million. Earnings were $14.46 million, an increase of 74.58%.

Financial numbers in USD Financial Statements

News

Kamada Confirms Continuous Global Business Operations and Products Availability Despite Recent Events in the Middle East

REHOVOT, Israel and HOBOKEN, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for r...

11 days ago - GlobeNewsWire

Kamada Q1 Results: Double-Digit Growth, Company Reiterates Guidance As It Hits Multiple Milestones Including Plasma Business Expansion

Kamada Ltd. (NASDAQ: KMDA) recently reported earnings for the first quarter of 2025, which saw revenue up 17% and Adjusted EBITDA up 54% year-over-year. The results help position Kamada to drive grow...

18 days ago - Benzinga

Kamada Reports Strong First Quarter 2025 Financial Results with Year Over Year Top Line Growth of 17% and a 54% Increase in Profitability

REHOVOT, Israel and HOBOKEN, N.J., May 14, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ra...

6 weeks ago - GlobeNewsWire

Earnings Scheduled For May 14, 2025

Companies Reporting Before The Bell • Cellebrite DI (NASDAQ: CLBT) is expected to report quarterly earnings at $0.09 per share on revenue of $109.36 million. • Banco Latinoamericano (NYSE: BLX) is p...

6 weeks ago - Benzinga

Kamada Q1 2025 Earnings Preview

6 weeks ago - Seeking Alpha

Earnings Preview For Kamada

Kamada (NASDAQ: KMDA) is set to give its latest quarterly earnings report on Wednesday, 2025-05-14. Here's what investors need to know before the announcement. Analysts estimate that Kamada will repo...

6 weeks ago - Benzinga

Kamada Announces Expansion of Plasma Collection Operations with the Opening of New Site in San Antonio, Texas

REHOVOT, Israel and HOBOKEN, N.J., March 19, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for ...

3 months ago - GlobeNewsWire

Kamada Announces Dividend After Record-Breaking Year, Anticipates Further Double-Digit Growth

Despite significant advancements in medical technologies and pharmaceutical advancements, certain conditions can only be addressed via plasma-derived medicines . This is especially the case for many r...

3 months ago - Benzinga

Kamada Ltd. (KMDA) Q4 2024 Earnings Call Transcript

Kamada Ltd. (NASDAQ:KMDA) Q4 2024 Earnings Conference Call March 5, 2025 8:00 AM ETCompany ParticipantsBrian Ritchie – LifeSci AdvisorsAmir London – Chief...

4 months ago - Seeking Alpha

Kamada declares $0.20 dividend

4 months ago - Seeking Alpha

Kamada Reports Record Top and Bottom Line 2024 Financial Results and Affirms 2025 Guidance Representing Double-Digit Profitable Growth

REHOVOT, Israel, and HOBOKEN, N.J., March 05, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for...

4 months ago - GlobeNewsWire

Earnings Scheduled For March 5, 2025

Companies Reporting Before The Bell • Full Truck Alliance Co (NYSE: YMM) is projected to report quarterly earnings at $0.14 per share on revenue of $419.04 million. • Brown Forman Inc Class B Common ...

4 months ago - Benzinga

Kamada Q4 2024 Earnings Preview

4 months ago - Seeking Alpha

Kamada to Announce Fourth Quarter and Fiscal Year 2024 Financial Results on March 5, 2025

REHOVOT, Israel, and HOBOKEN, N.J., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd.

4 months ago - GlobeNewsWire

Kamada Announces a $25 Million 3-Year Contract for Supply of KAMRAB® and VARIZIG® in Latin America

REHOVOT, Israel and HOBOKEN, N.J., Jan. 22, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for r...

5 months ago - GlobeNewsWire

Gauzy Appoints Seasoned Public Company Executive and Director Lilach Payorski to Board of Directors

Possesses more than 25 years' multinational finance and operations experience across a range of industries Currently serves as board member of publicly traded companies Oddity Tech and Kamada Ltd. Bec...

7 months ago - Benzinga

Phoenix Financial Ltd. Increases Stake in Kamada Ltd.

Phoenix Financial Ltd. Increases Stake in Kamada Ltd.

8 months ago - GuruFocus

Kamada Ltd. (KMDA) Q3 2024 Earnings Call Transcript

Call Start: 08:30 January 1, 0000 9:52 AM ETKamada Ltd.

8 months ago - Seeking Alpha

Kamada Reports Continued Profitable Growth with Strong Third Quarter and Nine Month 2024 Financial Results; Raises Full-Year Profitability Guidance

Revenues for Third Quarter of 2024 were $ 41.7 M illion , up 10 % Year-over-Year; Nine Month 2024 Total Revenues were $ 12 1 . 9 Million, u p 15 % Year -o ver - Year Third Quarter 2024 Adjusted EBITDA...

8 months ago - Benzinga

Earnings Scheduled For November 13, 2024

Companies Reporting Before The Bell • Davis Commodities (NASDAQ: DTCK) is expected to report earnings for its first quarter. • HIVE Digital Technologies (NASDAQ: HIVE) is estimated to report quarter...

8 months ago - Benzinga